tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corey Davis, 42 are a BUY (85.71%), 7 are a HOLD (14.29%).
Analyst Corey Davis, carries an average stock price target met ratio of 54.22% that have a potential upside of 33.99% achieved within 254 days. Previously, Corey Davis worked at HC WAINWRIGHT, JEFFERIES, CANACCORD, NATIONAL ALLIANCE.
Corey Davis’s has documented 95 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYNE, Zynerba Pharmaceuticals at 15-Aug-2023.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 10/13/2016. The price target of $20 was fulfilled within 167 days with a profit of $11.91 (147.22%) receiving and performance score of 8.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jun-2016
$2
$1.86 (1328.57%)
4 years 2 months 3 days ago
(09-May-2022)
6/7 (85.71%)
$0.8 (66.67%)
169
Sell Since 03-Mar-2022
$1
$0.86 (614.29%)
4 years 2 months 3 days ago
(09-May-2022)
3/3 (100%)
$-0.2 (-16.67%)
83
Hold Since 02-Mar-2022
$1
$0.86 (614.29%)
$3
4 years 2 months 6 days ago
(06-May-2022)
12/19 (63.16%)
$-0.42 (-29.58%)
91
Buy Since 24-Apr-2020
$6
$5.86 (4185.71%)
$11
4 years 4 months 3 days ago
(09-Mar-2022)
1/4 (25%)
$3.53 (142.91%)
250
Hold Since 09-Aug-2018
$17
4 years 8 months 7 days ago
(05-Nov-2021)
3/9 (33.33%)
$1.17 (7.39%)
101
What Year was the first public recommendation made by Corey Davis?
